Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Ginkgo Bioworks Holdings Inc., 3 years.
Ginkgo Bioworks Holdings Inc.
Director
Wave Life Sciences Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 11, 2025 | Ginkgo Bioworks Holdings Inc. | Option exercise | +10,822 | — | — |
| Mar 20, 2025 | Wave Life Sciences Inc. | Option exercise | +10,500 | $9.13 | $95,865 |
| Mar 20, 2025 | Wave Life Sciences Inc. | Open-market sale | −10,500 | $9.77 | $102,585 |
| Mar 19, 2025 | Pacific Biosciences of California Inc. | Grant or award | +920,810 | — | — |
| Mar 3, 2025 | Pacific Biosciences of California Inc. | Open-market sale | −12,497 | $1.41 | $17,621 |
| Feb 18, 2025 | Pacific Biosciences of California Inc. | Open-market sale | −259,909 | $1.88 | $488,629 |
| Sep 16, 2024 | Pacific Biosciences of California Inc. | Open-market sale | −98,907 | $1.75 | $173,087 |
| Aug 12, 2024 | Wave Life Sciences Inc. | Grant or award | +16,115 | — | — |
| Jun 12, 2024 | Ginkgo Bioworks Holdings Inc. | Option exercise | +105,263 | — | — |
| Mar 4, 2024 | Pacific Biosciences of California Inc. | Open-market sale | −14,177 | $4.87 | $69,042 |
| Feb 22, 2024 | Pacific Biosciences of California Inc. | Grant or award | +1,605,769 | — | — |
| Feb 20, 2024 | Pacific Biosciences of California Inc. | Open-market sale | −1,979 | $5.26 | $10,410 |
| Feb 16, 2024 | Pacific Biosciences of California Inc. | Open-market sale | −79,038 | $5.96 | $471,066 |
| Dec 14, 2023 | Pacific Biosciences of California Inc. | Open-market sale | −20,000 | $10.00 | $200,000 |
| Nov 2, 2023 | Ginkgo Bioworks Holdings Inc. | Open-market sale | −4,500 | $1.39 | $6,255 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.